InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,353.60
(
0.46%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.98
(
0.66%
)
Bitcoin
61,468.65
(
-0.22%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ronpopeil

Send PM Follow Ignore
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

ronpopeil

Re: None

Monday, 04/25/2022 7:54:29 AM

Monday, April 25, 2022 7:54:29 AM

Post# of 252412
$AXSM FDA has informed that the CMC issues identified during the review NDA for AXS-07 product candidate for the acute treatment of migraine are unresolved.

Based upon the time remaining in the NDA review cycle, the Company expects to receive a CRL with respect to this NDA

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up